Bulgaria – Various medicinal products – “Supply of medicinal products for 2026, dispensed pursuant to Ordinance No. 34 of 25.11.2005 on the procedure for payment from the state budget for the treatment of Bulgarian citizens for diseases outside the scope of mandatory health insurance, for the treatment of patients with HIV/AIDS, tuberculosis, mental and behavioral disorders due to opioid use, dependence syndrome,” comprising 22 lots
“Supply of medicinal products for 2026, dispensed pursuant to Ordinance No. 34 of 25.11.2005 on the procedure for payment from the state budget for the treatment of Bulgarian citizens for diseases outside the scope of mandatory health insur
Opportunity description
“Supply of medicinal products for 2026, dispensed pursuant to Ordinance No. 34 of 25.11.2005 on the procedure for payment from the state budget for the treatment of Bulgarian citizens for diseases outside the scope of mandatory health insurance, for the treatment of patients with HIV/AIDS, tuberculosis, mental and behavioral disorders due to opioid use, dependence syndrome,” comprising 22 lots” LAMIVUDINE - oral form - quantity up to 540 000 mg RALTEGRAVIR - oral form - quantity up to 102 384 000 mg RILPIVIRINE - oral form - quantity up to 207 000 mg DORAVIRINE/ LAMIVUDINE/ TENOFOVIR DISOPROXIL - oral form - quantity up to 211 320 tabl. BICTEGRAVIR/EMTRICITABINE/ TENOFOVIR ALAFENAMIDE - oral form - quantity up to 280 440 tabl. ISONIAZID - oral form - quantity up to 83 820 000 mg. RIFAMPICIN - oral form - quantity up to 155 610 000 mg. Procedure: open. Estimated value: 17,737,016.13 EUR. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.